Filing Details

Accession Number:
0000899243-20-005917
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-26 17:12:57
Reporting Period:
2020-01-27
Accepted Time:
2020-02-26 17:12:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
861838 Idera Pharmaceuticals Inc. IDRA Biological Products, (No Disgnostic Substances) (2836) 043072298
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193366 El Youssef Zein Pillar Invest Offshore Sal, Starco Ctr,
Bloc B, 3Rd Floor, Omar Daouk Street
Beirut M8 2020-3313
No No Yes No
1534425 Pillar Pharmaceuticals I Lp Pillar Invest Offshore Sal Starco Ctr,
Bloc B, 3Rd Floor, Omar Daouk Street
Beirut M8 2020-3313
No No Yes No
1534428 Pillar Invest Corp Pillar Invest Offshore Sal Starco Ctr,
Bloc B, 3Rd Floor, Omar Daouk Street
Beirut M8 2020-3313
No No Yes No
1562069 Pillar Pharmaceuticals Ii, L.p. Pillar Invest Offshore Sal, Starco Ctr,
Bloc B, 3Rd Floor, Omar Daouk Street
Beirut M8 2020-3313
No No Yes No
1576891 Pillar Pharmaceuticals Iii, L.p. Pillar Invest Offshore Sal Starco Ctr,
Bloc B, 3Rd Floor Omar Daouk Street
Beirut M8 2020-3313
No No Yes No
1588130 Pillar Pharmaceuticals Iv, L.p. Pillar Invest Offshore Sal Starco Ctr,
Bloc B, 3Rd Floor, Omar Daouk Street
Beirut M8 2020-3313
No No Yes No
1687312 Pillar Pharmaceuticals V Lp Pillar Invest Offshore Sal Starco Ctr,
Bloc B, 3Rd Floor, Omar Daouk Street
Beirut M8 2020-3313
No No Yes No
1783582 Abude Umari Pillar Invest Offshore Sal Starco Ctr,
Bloc B, 3Rd Floor, Omar Daouk Street
Beirut M8 2020-3313
No No Yes No
1783583 Pillar Partners Foundation, L.p. Pillar Invest Offshore Sal Starco Ctr
Bloc B, 3Rd Floor, Omar Daouk Street
Beirut M8 2020-3313
No No Yes No
1783584 Pillar Pharmaceuticals 6, L.p. Pillar Invest Offshore Sal Starco Ctr,
Bloc B, 3Rd Floor, Omar Daouk Street
Beirut M8 2020-3313
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-27 15,000 $1.77 3,284,224 No 4 S Indirect See Footnote
Common Stock Disposition 2020-01-28 12,532 $1.76 3,271,692 No 4 S Indirect See Footnote
Common Stock Disposition 2020-01-29 17,250 $1.76 3,254,442 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. Following this transaction, Pillar I owns directly 21,100 shares of common stock of the Issuer.
  2. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.76-$1.77. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  3. Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 20,820 shares of common stock of the Issuer.
  4. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.76-$1.7707. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  5. Shares sold by Pillar Pharmaceuticals III, L.P. ("Pillar III"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar III and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar III. Following the transactions on 1/28/20 and 1/29/20, Pillar III owns directly 29,998 shares of common stock of the Issuer.
  6. Shares sold by Pillar Pharmaceuticals V, L.P. ("Pillar V"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar V and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar V. Following this transaction, Pillar V owns directly 25,000 shares of common stock of the Issuer.